To study whether the decrease in degranulation translated into defective cytotoxicity, enriched CD8+ T cells from both CLL patients and HC were co-cultured with EBV-peptide loaded third-party B-cells and target cell death was analyzed by flow cytometry (Supplemental Fig. 2B+C). Here, CD8A is linked to B-cell chronic lymphocytic leukemia.